ARVN
ARVINAS, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.42
+4.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.89x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.95x
- Price / sales
- 1.76x
- Price / cash flow
- -3.07x
Enterprise value
- Enterprise value
- -$65.1M
- EV / sales
- -0.24x
- EV / EBITDA
- 3.00x
- EV / EBIT
- 2.21x
- Market cap
- $485.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026